Appropriate Sequence for Afatinib and Cisplatin Combination Improves Anticancer Activity in Head and Neck Squamous Cell Carcinoma

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00432
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Inhibition of Caspase-9 Activity in Cisplatin-Resistant Head and Neck Squamous Cell Carcinoma.

Journal of Otolaryngology of Japan
Otorhinolaryngology
2002English

Combination Immunotherapy of Squamous Cell Carcinoma of the Head and Neck

Archives of Otolaryngology–Head & Neck Surgery
2000English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck

American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer ResearchOncology
2016English

Hypersensitivity to Cisplatin After hRev3 mRNA Knockdown in Head and Neck Squamous Cell Carcinoma Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2008English

Head and Neck Squamous Cell Carcinoma Survivorship Care

2019English

Head and Neck Squamous Cell Carcinoma in Pregnant Women

Laryngoscope
Otorhinolaryngology
2011English

Adjuvant Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy